NHS - Neuberger Berman High Yield Strategies Fund Inc.

NYSE - NYSE Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
10/30/2017
10/30/2016
Total Revenue
5,580
25,818
29,237
Cost of Revenue
-
-
-
Gross Profit
-
-
-
Operating Expenses
Research Development
-
-
-
Selling General and Administrative
681
721
787
Total Operating Expenses
714
697
815
Operating Income or Loss
-
-
-
Interest Expense
2,458
2,133
1,663
Total Other Income/Expenses Net
-
-
-
Income Before Tax
4,866
25,120
28,422
Income Tax Expense
-
-
-
Income from Continuing Operations
4,866
25,120
28,422
Net Income
4,866
25,120
28,422
Net Income available to common shareholders
3,493
23,874
27,357
Reported EPS
Basic
-
1.22
1.40
Diluted
-
1.22
1.40
Weighted average shares outstanding
Basic
-
19,568
19,541
Diluted
-
19,568
19,541
EBITDA
-
-
-